Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
21 November, 2018 19:06 IST
Cadila Healthcare's Moraiya facility completes USFDA inspection
Source: IRIS | 12 Feb, 2018, 12.51PM
Comments  |  Post Comment

Cadila Healthcare announced that the USFDA inspected its Moraiya facility from February 5th to February 9th, 2018.  At the end of the inspection, no observation (483) is issued.

Zydus Cadila is an innovative, global pharmaceutical company that discovers, develops, manufactures and markets a broad range of healthcare therapies. The group employs over 21000 people worldwide and is dedicated to creating healthier communities globally. Zydus aspires to be a research-based pharmaceutical company by 2020.

Shares of the company gained Rs 13.35, or 3.25%, to trade at Rs 424.40. The total volume of shares traded was 68,658 at the BSE (12.38 p.m., Monday).



Cadila Healthcare Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Company Update
Dr. Reddy's Laboratories gets favourable decision in patent litigation in US court - 21-Nov-2018 09:38
Rajesh Exports bags export order worth Rs 9.33 bn - 21-Nov-2018 09:27
Gayatri Projects declared as lowest bidder for project worth Rs 1.62 bn - 20-Nov-2018 14:55
Ramco Systems wins contract from leading casino and resorts provider - 20-Nov-2018 14:52
Zydus Cadila receives tentative approval for Deferasirox tablets - 20-Nov-2018 14:49
Kridhan Infra arm wins orders worth Rs 1.95 bn - 20-Nov-2018 09:35
Glenmark Pharma receives approval for Azelaic acid gel - 20-Nov-2018 09:31
TCS partners with SAP to build intelligent rail digital maintenance solution - 20-Nov-2018 09:27
Vikas Ecotech to explore strategic inorganic growth opportunity - 19-Nov-2018 09:54
Zydus receives final approval from USFDA for Abacavir & Lamivudine Tablets and Fondaparinux Sodium Injection - 19-Nov-2018 09:51
Infosys starts construction of U.S education center in Indianapolis - 19-Nov-2018 09:41
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer